CDX
Asset Logo

Cardiex Limited

🇦🇺 ASX

🩺 HEALTH CARE

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-12.22%
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

7
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. The company specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.

📈 Performance

Price History

-88.83%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.10

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in CDX

7

📊 Total Capital Earnings

$4K

🔃 Average investment frequency

22 weeks

💵 Average investment amount

$804

Last time a customer invested in CDX

8 days
CDX investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

33%

50k - 100k

33%

Less than 50k

33%
👶 Age of investors

18 - 25

26 - 34

57%

35 - 90

43%
🙋 Legal gender of investors

Female

71%

Male

29%

Pearlers who invest in CDX also invest in...

Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

13.23%

📊 Share price

$134.96 AUD

🌏 GLOBAL

🤖 TECHNOLOGY

⛳️ DIVERSIFIED

📈 HIGH PRICE GROWTH

Find Out More

CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The company is engaged in designing, manufacturing, and marketing medical devices for use in cardiovascular health management, and the development of clinical and consumer digital health solutions. The company is focused on hypertension, cardiovascular disease, and other vascular health disorders. The company operates through its subsidiaries, including ATCOR and CONNEQT. ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its SphygmoCor technology. Under the ATCOR.X brand, it also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. Its digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients’ health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness parameters.

🩺 HEALTH CARE

📊 Share price

$0.47 AUD

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

4.00%

📊 Share price

$68.57 AUD

⛳️ DIVERSIFIED

🌏 GLOBAL

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

4.35%

📊 Share price

$104.33 AUD

⛳️ DIVERSIFIED

🧱 MATERIALS

💸 FINANCIALS

Want more shares? Try these...

📊 Share price

$0.04 AUD

Calima Energy Ltd. operates as an oil and gas exploration company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2006-07-28. The firm is engaged in the exploration and development of oil and natural gas assets in the Western Canadian Sedimentary Basin. The firm's focuses on maintaining production from the Paradise Field in British Columbia and acquiring additional oil and gas assets.

🙌 Performance (5Yr p.a)

0.78%

📊 Share price

$0.01 AUD

⚡️ ENERGY

📊 Share price

$0.00 AUD

📊 Share price

$0.00 AUD
Compare
Add to watchlist